Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

A trade-off between dry season survival longevity and wet season high net reproduction can explain the persistence of Anopheles mosquitoes.

Magombedze G, Ferguson NM, Ghani AC.

Parasit Vectors. 2018 Nov 3;11(1):576. doi: 10.1186/s13071-018-3158-0.

2.

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning.

Dorigatti I, Donnelly CA, Laydon DJ, Small R, Jackson N, Coudeville L, Ferguson NM.

Nat Commun. 2018 Sep 7;9(1):3644. doi: 10.1038/s41467-018-06006-6.

3.

Challenges and opportunities in controlling mosquito-borne infections.

Ferguson NM.

Nature. 2018 Jul;559(7715):490-497. doi: 10.1038/s41586-018-0318-5. Epub 2018 Jul 25. Review.

PMID:
30046071
4.

Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design.

Imai N, Ferguson NM.

PLoS One. 2018 Jun 26;13(6):e0199450. doi: 10.1371/journal.pone.0199450. eCollection 2018.

5.

Mathematical models of human mobility of relevance to malaria transmission in Africa.

Marshall JM, Wu SL, Sanchez C HM, Kiware SS, Ndhlovu M, Ouédraogo AL, Touré MB, Sturrock HJ, Ghani AC, Ferguson NM.

Sci Rep. 2018 May 16;8(1):7713. doi: 10.1038/s41598-018-26023-1.

6.

Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions.

Anders KL, Cutcher Z, Kleinschmidt I, Donnelly CA, Ferguson NM, Indriani C, Ryan PA, O'Neill SL, Jewell NP, Simmons CP.

Am J Epidemiol. 2018 Sep 1;187(9):2021-2028. doi: 10.1093/aje/kwy099.

7.

Age and Mortality in Pediatric Severe Traumatic Brain Injury: Results from an International Study.

Sarnaik A, Ferguson NM, O'Meara AMI, Agrawal S, Deep A, Buttram S, Bell MJ, Wisniewski SR, Luther JF, Hartman AL, Vavilala MS; Investigators of the ADAPT Trial.

Neurocrit Care. 2018 Jun;28(3):302-313. doi: 10.1007/s12028-017-0480-x.

PMID:
29476389
8.

Using Wolbachia for Dengue Control: Insights from Modelling.

Dorigatti I, McCormack C, Nedjati-Gilani G, Ferguson NM.

Trends Parasitol. 2018 Feb;34(2):102-113. doi: 10.1016/j.pt.2017.11.002. Epub 2017 Nov 25. Review.

9.

International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017.

Dorigatti I, Hamlet A, Aguas R, Cattarino L, Cori A, Donnelly CA, Garske T, Imai N, Ferguson NM.

Euro Surveill. 2017 Jul 13;22(28). pii: 30572. doi: 10.2807/1560-7917.ES.2017.22.28.30572.

10.

Key data for outbreak evaluation: building on the Ebola experience.

Cori A, Donnelly CA, Dorigatti I, Ferguson NM, Fraser C, Garske T, Jombart T, Nedjati-Gilani G, Nouvellet P, Riley S, Van Kerkhove MD, Mills HL, Blake IM.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160371. doi: 10.1098/rstb.2016.0371. Review.

11.

Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016.

Garske T, Cori A, Ariyarajah A, Blake IM, Dorigatti I, Eckmanns T, Fraser C, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Newton E, Nouvellet P, Perkins D, Riley S, Schumacher D, Shah A, Van Kerkhove MD, Dye C, Ferguson NM, Donnelly CA.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160308. doi: 10.1098/rstb.2016.0308.

12.

A simple approach to measure transmissibility and forecast incidence.

Nouvellet P, Cori A, Garske T, Blake IM, Dorigatti I, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Van Kerkhove MD, Fraser C, Donnelly CA, Ferguson NM, Riley S.

Epidemics. 2018 Mar;22:29-35. doi: 10.1016/j.epidem.2017.02.012. Epub 2017 Feb 24.

13.

A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination.

Jean K, Donnelly CA, Ferguson NM, Garske T.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1435-1439. Epub 2016 Oct 10.

14.

Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study.

International Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Bawo L, Bilivogui P, Blake IM, Brennan RJ, Cawthorne A, Cleary E, Clement P, Conteh R, Cori A, Dafae F, Dahl B, Dangou JM, Diallo B, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Fallah M, Ferguson NM, Fiebig L, Fraser C, Garske T, Gonzalez L, Hamblion E, Hamid N, Hersey S, Hinsley W, Jambei A, Jombart T, Kargbo D, Keita S, Kinzer M, George FK, Godefroy B, Gutierrez G, Kannangarage N, Mills HL, Moller T, Meijers S, Mohamed Y, Morgan O, Nedjati-Gilani G, Newton E, Nouvellet P, Nyenswah T, Perea W, Perkins D, Riley S, Rodier G, Rondy M, Sagrado M, Savulescu C, Schafer IJ, Schumacher D, Seyler T, Shah A, Van Kerkhove MD, Wesseh CS, Yoti Z.

PLoS Med. 2016 Nov 15;13(11):e1002170. doi: 10.1371/journal.pmed.1002170. eCollection 2016 Nov.

15.

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

Ferguson NM, Rodríguez-Barraquer I, Dorigatti I, Mier-Y-Teran-Romero L, Laydon DJ, Cummings DA.

Science. 2016 Sep 2;353(6303):1033-1036.

16.

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.

WHO Ebola Response Team, Agua-Agum J, Allegranzi B, Ariyarajah A, Aylward R, Blake IM, Barboza P, Bausch D, Brennan RJ, Clement P, Coffey P, Cori A, Donnelly CA, Dorigatti I, Drury P, Durski K, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garcia E, Garske T, Gasasira A, Gurry C, Hamblion E, Hinsley W, Holden R, Holmes D, Hugonnet S, Jaramillo Gutierrez G, Jombart T, Kelley E, Santhana R, Mahmoud N, Mills HL, Mohamed Y, Musa E, Naidoo D, Nedjati-Gilani G, Newton E, Norton I, Nouvellet P, Perkins D, Perkins M, Riley S, Schumacher D, Shah A, Tang M, Varsaneux O, Van Kerkhove MD.

N Engl J Med. 2016 Aug 11;375(6):587-96. doi: 10.1056/NEJMsr1513109. No abstract available.

17.

Unraveling the drivers of MERS-CoV transmission.

Cauchemez S, Nouvellet P, Cori A, Jombart T, Garske T, Clapham H, Moore S, Mills HL, Salje H, Collins C, Rodriquez-Barraquer I, Riley S, Truelove S, Algarni H, Alhakeem R, AlHarbi K, Turkistani A, Aguas RJ, Cummings DA, Van Kerkhove MD, Donnelly CA, Lessler J, Fraser C, Al-Barrak A, Ferguson NM.

Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9081-6. doi: 10.1073/pnas.1519235113. Epub 2016 Jul 25.

18.

Assessing the global threat from Zika virus.

Lessler J, Chaisson LH, Kucirka LM, Bi Q, Grantz K, Salje H, Carcelen AC, Ott CT, Sheffield JS, Ferguson NM, Cummings DA, Metcalf CJ, Rodriguez-Barraquer I.

Science. 2016 Aug 12;353(6300):aaf8160. doi: 10.1126/science.aaf8160. Epub 2016 Jul 14. Review.

19.

EPIDEMIOLOGY. Countering the Zika epidemic in Latin America.

Ferguson NM, Cucunubá ZM, Dorigatti I, Nedjati-Gilani GL, Donnelly CA, Basáñez MG, Nouvellet P, Lessler J.

Science. 2016 Jul 22;353(6297):353-4. doi: 10.1126/science.aag0219. Epub 2016 Jul 14. No abstract available.

20.

Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries.

Imai N, Dorigatti I, Cauchemez S, Ferguson NM.

PLoS Negl Trop Dis. 2016 Jul 11;10(7):e0004833. doi: 10.1371/journal.pntd.0004833. eCollection 2016 Jul.

21.

Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study.

Walker PG, Griffin JT, Ferguson NM, Ghani AC.

Lancet Glob Health. 2016 Jul;4(7):e474-84. doi: 10.1016/S2214-109X(16)30073-0. Epub 2016 Jun 3.

22.

Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance.

Clapham HE, Quyen TH, Kien DT, Dorigatti I, Simmons CP, Ferguson NM.

PLoS Comput Biol. 2016 May 23;12(5):e1004951. doi: 10.1371/journal.pcbi.1004951. eCollection 2016 May.

23.

Key traveller groups of relevance to spatial malaria transmission: a survey of movement patterns in four sub-Saharan African countries.

Marshall JM, Touré M, Ouédraogo AL, Ndhlovu M, Kiware SS, Rezai A, Nkhama E, Griffin JT, Hollingsworth TD, Doumbia S, Govella NJ, Ferguson NM, Ghani AC.

Malar J. 2016 Apr 12;15:200. doi: 10.1186/s12936-016-1252-3.

24.

Use of serological surveys to generate key insights into the changing global landscape of infectious disease.

Metcalf CJ, Farrar J, Cutts FT, Basta NE, Graham AL, Lessler J, Ferguson NM, Burke DS, Grenfell BT.

Lancet. 2016 Aug 13;388(10045):728-30. doi: 10.1016/S0140-6736(16)30164-7. Epub 2016 Apr 5. No abstract available.

25.

Survival After Cardiac Arrest: ECMO Rescue Therapy After Amlodipine and Metoprolol Overdose.

Maskell KF, Ferguson NM, Bain J, Wills BK.

Cardiovasc Toxicol. 2017 Apr;17(2):223-225. doi: 10.1007/s12012-016-9362-2.

PMID:
26913719
26.

Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models.

Pothin E, Ferguson NM, Drakeley CJ, Ghani AC.

Malar J. 2016 Feb 9;15:79. doi: 10.1186/s12936-016-1121-0.

27.

Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia.

Lessler J, Salje H, Van Kerkhove MD, Ferguson NM, Cauchemez S, Rodriquez-Barraquer I, Hakeem R, Jombart T, Aguas R, Al-Barrak A, Cummings DA; MERS-CoV Scenario and Modeling Working Group.

Am J Epidemiol. 2016 Apr 1;183(7):657-63. doi: 10.1093/aje/kwv452. Epub 2016 Feb 4.

28.

Model-Based Comprehensive Analysis of School Closure Policies for Mitigating Influenza Epidemics and Pandemics.

Fumanelli L, Ajelli M, Merler S, Ferguson NM, Cauchemez S.

PLoS Comput Biol. 2016 Jan 21;12(1):e1004681. doi: 10.1371/journal.pcbi.1004681. eCollection 2016 Jan.

29.

Ebola Virus Disease among Male and Female Persons in West Africa.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garske T, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Newton E, Nouvellet P, Perkins D, Riley S, Schumacher D, Shah A, Thomas LJ, Van Kerkhove MD.

N Engl J Med. 2016 Jan 7;374(1):96-8. doi: 10.1056/NEJMc1510305. No abstract available.

30.

A systematic review of reported reassortant viral lineages of influenza A.

Pinsent A, Fraser C, Ferguson NM, Riley S.

BMC Infect Dis. 2016 Jan 5;16:3. doi: 10.1186/s12879-015-1298-9. Review.

31.

Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury--Results From an Automated Data Collection System Time-Synched to Drug Administration.

Shein SL, Ferguson NM, Kochanek PM, Bayir H, Clark RS, Fink EL, Tyler-Kabara EC, Wisniewski SR, Tian Y, Balasubramani GK, Bell MJ.

Pediatr Crit Care Med. 2016 Mar;17(3):236-45. doi: 10.1097/PCC.0000000000000610.

32.

The role of rapid diagnostics in managing Ebola epidemics.

Nouvellet P, Garske T, Mills HL, Nedjati-Gilani G, Hinsley W, Blake IM, Van Kerkhove MD, Cori A, Dorigatti I, Jombart T, Riley S, Fraser C, Donnelly CA, Ferguson NM.

Nature. 2015 Dec 3;528(7580):S109-16. doi: 10.1038/nature16041.

33.

Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, Ferguson NM, Garske T, Mills HL, Riley S, Van Kerkhove MD, Hernán MA.

PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003846. doi: 10.1371/journal.pntd.0003846. eCollection 2015. Review.

34.

Assessing the epidemiological effect of wolbachia for dengue control.

Lambrechts L, Ferguson NM, Harris E, Holmes EC, McGraw EA, O'Neill SL, Ooi EE, Ritchie SA, Ryan PA, Scott TW, Simmons CP, Weaver SC.

Lancet Infect Dis. 2015 Jul;15(7):862-6. doi: 10.1016/S1473-3099(15)00091-2. Epub 2015 Jun 4. Review.

35.

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.

Dorigatti I, Aguas R, Donnelly CA, Guy B, Coudeville L, Jackson N, Saville M, Ferguson NM.

Vaccine. 2015 Jul 17;33(31):3746-51. doi: 10.1016/j.vaccine.2015.05.059. Epub 2015 Jun 4.

36.

A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making.

Van Kerkhove MD, Bento AI, Mills HL, Ferguson NM, Donnelly CA.

Sci Data. 2015 May 26;2:150019. doi: 10.1038/sdata.2015.19. eCollection 2015.

37.

Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis.

Walker PG, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani AC.

Lancet Infect Dis. 2015 Jul;15(7):825-32. doi: 10.1016/S1473-3099(15)70124-6. Epub 2015 Apr 23.

38.

A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM.

PLoS Comput Biol. 2015 Apr 23;11(4):e1004138. doi: 10.1371/journal.pcbi.1004138. eCollection 2015 Apr.

39.

Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries.

Imai N, Dorigatti I, Cauchemez S, Ferguson NM.

PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003719. doi: 10.1371/journal.pntd.0003719. eCollection 2015 Apr.

40.

Ebola virus disease among children in West Africa.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Fowler RA, Fraser C, Garske T, Hinsley W, Jombart T, Mills HL, Murthy S, Nedjati Gilani G, Nouvellet P, Pelletier L, Riley S, Schumacher D, Shah A, Van Kerkhove MD.

N Engl J Med. 2015 Mar 26;372(13):1274-7. doi: 10.1056/NEJMc1415318. No abstract available.

41.

Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti.

Ferguson NM, Kien DT, Clapham H, Aguas R, Trung VT, Chau TN, Popovici J, Ryan PA, O'Neill SL, McGraw EA, Long VT, Dui le T, Nguyen HL, Chau NV, Wills B, Simmons CP.

Sci Transl Med. 2015 Mar 18;7(279):279ra37. doi: 10.1126/scitranslmed.3010370.

42.

Emerging therapies in traumatic brain injury.

Kochanek PM, Jackson TC, Ferguson NM, Carlson SW, Simon DW, Brockman EC, Ji J, Bayır H, Poloyac SM, Wagner AK, Kline AE, Empey PE, Clark RS, Jackson EK, Dixon CE.

Semin Neurol. 2015 Feb;35(1):83-100. doi: 10.1055/s-0035-1544237. Epub 2015 Feb 25. Review.

43.

Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014.

Lessler J, Rodriguez-Barraquer I, Cummings DA, Garske T, Van Kerkhove M, Mills H, Truelove S, Hakeem R, Albarrak A, Ferguson NM; MERS-CoV Scenario Modeling Working Group; MERS-CoV Scenario Modeling Working Group.

PLoS Curr. 2014 Nov 24;6. pii: ecurrents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369. doi: 10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369.

44.

West African Ebola epidemic after one year--slowing but not yet under control.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fraser C, Garcia E, Garske T, Hinsley W, Holmes D, Hugonnet S, Iyengar S, Jombart T, Krishnan R, Meijers S, Mills HL, Mohamed Y, Nedjati-Gilani G, Newton E, Nouvellet P, Pelletier L, Perkins D, Riley S, Sagrado M, Schnitzler J, Schumacher D, Shah A, Van Kerkhove MD, Varsaneux O, Wijekoon Kannangarage N.

N Engl J Med. 2015 Feb 5;372(6):584-7. doi: 10.1056/NEJMc1414992. Epub 2014 Dec 24. No abstract available.

45.

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.

Okell LC, Cairns M, Griffin JT, Ferguson NM, Tarning J, Jagoe G, Hugo P, Baker M, D'Alessandro U, Bousema T, Ubben D, Ghani AC.

Nat Commun. 2014 Nov 26;5:5606. doi: 10.1038/ncomms6606.

46.

Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach.

Pelat C, Ferguson NM, White PJ, Reed C, Finelli L, Cauchemez S, Fraser C.

Am J Epidemiol. 2014 Nov 15;180(10):1036-46. doi: 10.1093/aje/kwu213. Epub 2014 Sep 25.

47.

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

WHO Ebola Response Team, Aylward B, Barboza P, Bawo L, Bertherat E, Bilivogui P, Blake I, Brennan R, Briand S, Chakauya JM, Chitala K, Conteh RM, Cori A, Croisier A, Dangou JM, Diallo B, Donnelly CA, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fuhrer C, Fukuda K, Garske T, Gasasira A, Gbanyan S, Graaff P, Heleze E, Jambai A, Jombart T, Kasolo F, Kadiobo AM, Keita S, Kertesz D, Koné M, Lane C, Markoff J, Massaquoi M, Mills H, Mulba JM, Musa E, Myhre J, Nasidi A, Nilles E, Nouvellet P, Nshimirimana D, Nuttall I, Nyenswah T, Olu O, Pendergast S, Perea W, Polonsky J, Riley S, Ronveaux O, Sakoba K, Santhana Gopala Krishnan R, Senga M, Shuaib F, Van Kerkhove MD, Vaz R, Wijekoon Kannangarage N, Yoti Z.

N Engl J Med. 2014 Oct 16;371(16):1481-95. doi: 10.1056/NEJMoa1411100. Epub 2014 Sep 22.

48.

Determinants of influenza transmission in South East Asia: insights from a household cohort study in Vietnam.

Cauchemez S, Ferguson NM, Fox A, Mai le Q, Thanh le T, Thai PQ, Thoang DD, Duong TN, Minh Hoa le N, Tran Hien N, Horby P.

PLoS Pathog. 2014 Aug 21;10(8):e1004310. doi: 10.1371/journal.ppat.1004310. eCollection 2014 Aug.

49.

How season and serotype determine dengue transmissibility.

Ferguson NM, Cummings DA.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9370-1. doi: 10.1073/pnas.1407648111. Epub 2014 Jun 9. No abstract available.

50.

Within-host viral dynamics of dengue serotype 1 infection.

Clapham HE, Tricou V, Van Vinh Chau N, Simmons CP, Ferguson NM.

J R Soc Interface. 2014 Jul 6;11(96). pii: 20140094. doi: 10.1098/rsif.2014.0094.

Supplemental Content

Loading ...
Support Center